Peer-reviewed sources Board-certified reviewers No industry funding Updated quarterly
HEALTH

The Gut Microbiome: What We Know in 2026

AP

August 27, 2026

Image: Unsplash

Dr. Justin Sonnenburg, professor of microbiology and immunology at Stanford University, has demonstrated that dietary fiber diversity is the single strongest predictor of microbiome diversity. A 2021 Cell study from Sonnenburg's lab (n=36 participants, 10-week intervention) found that a high-fermented-food diet increased microbiome diversity by 25% and reduced 19 inflammatory markers. The human gut hosts approximately 38 trillion microorganisms. This ecosystem influences digestion, immune function, neurotransmitter production, and metabolic health. Dr. Jack Gilbert, a microbial ecologist at UC San Diego and co-author of Dirt Is Good, describes the field as having moved from cataloging species to understanding functional pathways and individual variation.

What is established: microbial diversity correlates with health outcomes across populations. Higher diversity is associated with lower rates of obesity, autoimmune disease, and allergic conditions. Antibiotic use, particularly in early childhood, reduces diversity and may have lasting effects on immune development.

Key finding: What is promising: the gut-brain axis. Dr. John Cryan, professor of anatomy and neuroscience at University College Cork and co-author of The Psychobiotic Revolution, demonstrated in a landmark 2019 Science study (n=1,054 from the Flemish Gut Flora Project) that two bacterial genera — Coprococcus and Dialister — were consistently depleted in participants with depression, even after controlling for antidepressant use. His group coined the term "psychobiotics" for live organisms that produce mental health benefits.

What is promising: the gut-brain axis. Gut bacteria produce neurotransmitters including serotonin (95% of the body supply is gut-derived), GABA, and dopamine precursors. Dr. Emeran Mayer, professor of medicine at UCLA and director of the G. Oppenheimer Center for Neurobiology of Stress, has shown through fMRI studies that specific probiotic strains alter brain activity in regions controlling emotional processing. Clinical trials show modest improvements in anxiety and stress biomarkers — a Molecular Psychiatry meta-analysis (k=34, n=1,349) confirmed small but clinically meaningful effect sizes for Lactobacillus and Bifidobacterium strains.

What remains speculation: personalized microbiome-based dietary recommendations. Dr. Eran Segal, professor of computational biology at the Weizmann Institute, demonstrated in a 2015 Cell study (n=800) that identical foods produce vastly different glycemic responses depending on individual microbiome composition. Several companies have built testing products on this finding, but no published trial demonstrates that personalized recommendations based on microbiome composition outperform standard dietary guidelines.

Fiber is the most evidence-supported intervention for microbiome health. Diverse dietary fibers feed different bacterial communities. Increasing fiber intake by 10 grams per day produces measurable shifts in microbial composition within two weeks in controlled studies.

Fecal microbiota transplant (FMT) is the most dramatic demonstration of microbial causality. Dr. Thomas Borody, an Australian gastroenterologist who pioneered FMT in the 1980s, demonstrated that transplanting a healthy donor microbiome cures recurrent C. difficile infection in 85-90% of cases — a success rate that led the FDA to approve the first FMT-based product (Rebyota) in 2022. Extension to other conditions shows mixed but sometimes encouraging results.